About Protalex Inc

Protalex, Inc. is a development stage company engaged in developing a class of biopharmaceutical drugs for treating autoimmune and inflammatory diseases. The Company's lead product is PRTX-100. The autoimmune diseases initially targeted by the Company are pemphigus and rheumatoid arthritis (RA). In autoimmune disease models, PRTX-100, which is a natural compound, has reversed the pathologic process resulting in a restoration and maintenance of normal healthy tissue.